Keyphrases
Pharmacokinetics
100%
Type 1 Diabetes Mellitus (T1DM)
100%
TB Drugs
100%
Rifampicin
66%
Patients with Diabetes Mellitus
50%
Maximum Permissible Concentration
50%
Pyrazinamide
50%
Meta-analysis
33%
Plasma Concentration
33%
Ethambutol
33%
Clinical Outcomes
16%
Systematic Meta-analysis
16%
No Significant Difference
16%
High Dose
16%
Drug Resistance
16%
Area under the Curve
16%
Drug Concentration
16%
Treatment Failure
16%
Patients with Diabetes
16%
Diabetes Mellitus Patients
16%
Poor Clinical Outcomes
16%
Prospero
16%
Cmax
16%
Dose Limits
16%
Culture Conversion
16%
Second-line Anti-tuberculosis Drugs
16%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Pharmacokinetics
100%
Rifampicin
44%
Pyrazinamide
33%
Isoniazid
33%
Ethambutol
22%
Drug Resistance
11%
Drug Concentration
11%
Dose Limit
11%
Immunology and Microbiology
Pharmacokinetics
100%
Blood Level
50%
Drug Concentration
25%
Drug Megadose
25%
Drug Resistance
25%
Body Weight
25%
Maximum Concentration
25%